RhumbLine Advisers’s Applied Molecular Transport Inc. Common Stock AMTI Stock Holding History

RhumbLine Advisers’s Portfolio AMTI Stock Details AMTI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-24,335	Closed	-$183K	–	3287
2022 Q1	$183K	Buy	24,335 +1,517	+7%	+$12.6K	﹤0.01%	2780
2021 Q4	$319K	Sell	22,818 -433	-2%	-$8.54K	﹤0.01%	2685
2021 Q3	$602K	Buy	23,251 +1,120	+5%	+$35.5K	﹤0.01%	2458
2021 Q2	$1.01M	Sell	22,131 -1,556	-7%	-$73.6K	﹤0.01%	2242
2021 Q1	$1.04M	Buy	23,687 +10,119	+75%	+$492K	﹤0.01%	2174
2020 Q4	$417K	Buy	13,568 +2,007	+17%	+$63.6K	﹤0.01%	2509
2020 Q3	$368K	Buy	+11,561	New	+$284K	﹤0.01%	2428

Other funds holding AMTI

ECG

EPIQ Capital Group San Francisco, California $383M AUM 46.87% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

FFVM

Founders Fund V Management San Francisco, California $2.16M AUM 77.37% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FFVM

Founders Fund VI Management San Francisco, California $45.8K AUM 58.63% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

LCM

Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

RhumbLine Advisers's AMTI Position: Q2 2022 in Review

RhumbLine Advisers sold out of Applied Molecular Transport Inc. Common Stock (AMTI) in Q2 2022, closing a stake of 24,335 shares — an estimated $183K sold.

RhumbLine Advisers first reported a position in AMTI in Q3 2020 and held it in 7 quarters. The position peaked at $1.04M in Q1 2021. 56 funds tracked by Wall St. Rank hold AMTI as of Q2 2022.

RhumbLine Advisers reported no remaining Applied Molecular Transport Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
RhumbLine Advisers sold 24,335 Applied Molecular Transport Inc. Common Stock shares in Q2 2022, an estimated $183K.
RhumbLine Advisers first reported a position in Applied Molecular Transport Inc. Common Stock in Q3 2020 and held it in 7 quarters.
RhumbLine Advisers's Applied Molecular Transport Inc. Common Stock position peaked at $1.04M in Q1 2021.
56 funds tracked by Wall St. Rank held Applied Molecular Transport Inc. Common Stock as of Q2 2022.

Based on RhumbLine Advisers's 13F filing for Q2 2022, filed 11 Aug 2022.